Complete Filing Data
Chime Financial, Inc. reported Temporary Equity Shares Outstanding of 0 shares for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Chime Financial, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Income Loss | -$1.01B | -$25.3M | -$203.2M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$31.0K | -$517.0K | $7.5M |
| Selling And Marketing Expense | $635.4M | $519.8M | $443.8M |
| Revenues | $2.19B | $1.67B | $1.28B |
| Research And Development Expense | $934.9M | $309.6M | $259.0M |
| Other Nonoperating Income Expense | $30.9M | $39.5M | $32.8M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $377.0K | $57.0K | $7.4M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$408.0K | -$574.0K | $139.0K |
| Operating Income Loss | -$1.04B | -$62.2M | -$235.8M |
| Operating Expenses | $2.96B | $1.53B | $1.29B |
| Income Tax Expense Benefit | $831.0K | $2.6M | $234.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$1.01B | -$22.7M | -$203.0M |
| Gross Profit | $1.92B | $1.47B | $1.06B |
| General And Administrative Expense | $512.1M | $177.2M | $154.9M |
| Cost Of Goods And Services Sold | $263.0M | $207.5M | $219.7M |
| Comprehensive Income Net Of Tax | -$1.01B | -$25.9M | -$195.7M |
| Income Taxes Paid | $1.1M | $2.2M | $275.0K |
| Asset Impairment Charges | $0.00 | $1.9M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Net Income Loss | -$54.7M | -$923.4M | $12.9M | -$22.0M | $385.0K | $15.9M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $37.0K | -$410.0K | $91.0K | $3.6M | -$382.0K | -$1.3M |
| Selling And Marketing Expense | $153.6M | $185.0M | $143.1M | $118.0M | ||
| Revenues | $543.5M | $528.1M | $421.9M | $384.2M | ||
| Research And Development Expense | $123.9M | $621.8M | $80.4M | $75.4M | ||
| Other Nonoperating Income Expense | $10.3M | $6.2M | $10.8M | $9.9M | ||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $915.0K | -$752.0K | $3.5M | -$300.0K | ||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$878.0K | $342.0K | $81.0K | -$82.0K | ||
| Operating Income Loss | -$64.7M | -$930.6M | -$30.6M | -$9.4M | ||
| Operating Expenses | $538.8M | $1.39B | $399.0M | $343.2M | ||
| Income Tax Expense Benefit | $280.0K | -$1.0M | $2.2M | $78.0K | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$54.4M | -$924.4M | -$19.8M | $463.0K | ||
| Gross Profit | $474.1M | $461.0M | $368.4M | $333.7M | ||
| General And Administrative Expense | $76.6M | $279.7M | $46.6M | $41.6M | ||
| Cost Of Goods And Services Sold | $69.4M | $67.1M | $53.5M | $50.5M | ||
| Comprehensive Income Net Of Tax | -$54.7M | -$923.8M | -$18.4M | $3.0K | ||
| Income Taxes Paid | ||||||
| Asset Impairment Charges |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $2.89B | $2.89B | $2.89B |
| Stockholders Equity | $1.40B | -$1.93B | -$1.95B | -$1.79B |
| Restricted Cash And Cash Equivalents | $14.5M | $12.3M | $0.00 | |
| Cash And Cash Equivalents At Carrying Value | $466.3M | $337.7M | $239.7M | |
| Redeemable Convertible Preferred Stock Converted Into Permanent Equity Common Stock Upon Initial Public Offering | $2.89B | $0.00 | $0.00 | |
| Reclassification Of Deferred Offering Costs To Additional Paid In Capital Upon Initial Public Offering | $14.8M | $0.00 | $0.00 | |
| Other Operating Activities Cash Flow Statement | -$94.0K | $97.0K | $1.3M | |
| Noncash Lease Expense | $7.2M | $5.5M | $5.4M | |
| Fair Value Adjustment Of Derivative Liability | $41.8M | $59.4M | $85.0M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $130.8M | $110.3M | $11.3M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $350.0M | $239.7M | $228.5M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $480.8M | $350.0M | $239.7M | |
| Amortization Of Debt Discount Premium | -$5.1M | -$12.5M | -$14.8M | |
| Retained Earnings Accumulated Deficit | -$3.37B | -$2.36B | ||
| Prepaid Expense And Other Assets Current | $106.8M | $70.5M | ||
| Preferred Stock Value | $0.00 | $0.00 | ||
| Other Liabilities Noncurrent | $51.7M | $46.1M | ||
| Other Assets | $30.8M | $32.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $0.00 | $2.89B | $2.89B | $2.89B | $2.89B |
| Stockholders Equity | $1.44B | $1.43B | -$1.91B | -$1.92B | -$1.91B | -$1.93B |
| Restricted Cash And Cash Equivalents | $13.7M | $13.5M | $10.0M | $10.0M | ||
| Cash And Cash Equivalents At Carrying Value | $445.0M | $868.3M | $270.8M | $295.4M | ||
| Redeemable Convertible Preferred Stock Converted Into Permanent Equity Common Stock Upon Initial Public Offering | ||||||
| Reclassification Of Deferred Offering Costs To Additional Paid In Capital Upon Initial Public Offering | ||||||
| Other Operating Activities Cash Flow Statement | ||||||
| Noncash Lease Expense | ||||||
| Fair Value Adjustment Of Derivative Liability | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $458.7M | $881.8M | $280.8M | $305.4M | ||
| Amortization Of Debt Discount Premium | ||||||
| Retained Earnings Accumulated Deficit | -$3.33B | -$3.27B | ||||
| Prepaid Expense And Other Assets Current | $90.9M | $72.5M | ||||
| Preferred Stock Value | $0.00 | $0.00 | ||||
| Other Liabilities Noncurrent | $37.3M | $39.9M | ||||
| Other Assets | $31.3M | $31.7M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Depreciation Depletion And Amortization Excluding Deprecation Included In Cost Of Sales | $16.0M | $14.9M | $11.6M |
| Share Based Compensation | $1.07B | $29.8M | $26.0M |
| Proceeds From Stock Options Exercised | $25.2M | $1.4M | $1.7M |
| Proceeds From Sale Of Available For Sale Securities Debt | $256.5M | $193.2M | $0.00 |
| Proceeds From Sale And Maturity Of Marketable Securities | $264.7M | $508.3M | $805.5M |
| Proceeds From Sale And Collection Of Finance Receivables | $4.89B | $1.73B | $0.00 |
| Proceeds From Issuance Initial Public Offering | $770.6M | $0.00 | $0.00 |
| Payments To Acquire Finance Receivables | $4.94B | $1.86B | $0.00 |
| Payments To Acquire Businesses Net Of Cash Acquired | $0.00 | $13.3M | $0.00 |
| Payments To Acquire Available For Sale Securities Debt | $735.0M | $497.6M | $610.7M |
| Payments Related To Tax Withholding For Share Based Compensation | $349.4M | $0.00 | $0.00 |
| Payments Of Debt Issuance Costs | $1.1M | $0.00 | $830.0K |
| Payments For Repurchase Of Common Stock | $77.5M | $950.0K | $61.0K |
| Net Cash Provided By Used In Operating Activities | $52.8M | $64.1M | -$156.6M |
| Net Cash Provided By Used In Investing Activities | -$289.7M | $45.7M | $167.0M |
| Net Cash Provided By Used In Financing Activities | $367.7M | $456.0K | $842.0K |
| Increase Decrease In Product Collateral | $69.5M | $43.0M | $11.8M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $23.6M | $24.1M | -$12.2M |
| Increase Decrease In Operating Lease Liability | -$14.9M | -$10.5M | $2.4M |
| Increase Decrease In Derivative Liabilities | -$8.7M | -$33.6M | -$76.3M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$77.4M | $33.6M | -$11.3M |
| Increase Decrease In Accounts Receivable | $43.0M | $40.3M | $53.3M |
| Increase Decrease In Accounts Payable | $2.8M | $13.7M | $1.4M |
| Depreciation Depletion And Amortization | $30.0M | $25.4M | $12.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Depreciation Depletion And Amortization Excluding Deprecation Included In Cost Of Sales | $4.0M | $3.9M | $3.6M | $3.3M |
| Share Based Compensation | ||||
| Proceeds From Stock Options Exercised | ||||
| Proceeds From Sale Of Available For Sale Securities Debt | ||||
| Proceeds From Sale And Maturity Of Marketable Securities | ||||
| Proceeds From Sale And Collection Of Finance Receivables | ||||
| Proceeds From Issuance Initial Public Offering | ||||
| Payments To Acquire Finance Receivables | ||||
| Payments To Acquire Businesses Net Of Cash Acquired | ||||
| Payments To Acquire Available For Sale Securities Debt | ||||
| Payments Related To Tax Withholding For Share Based Compensation | ||||
| Payments Of Debt Issuance Costs | ||||
| Payments For Repurchase Of Common Stock | ||||
| Net Cash Provided By Used In Operating Activities | ||||
| Net Cash Provided By Used In Investing Activities | ||||
| Net Cash Provided By Used In Financing Activities | ||||
| Increase Decrease In Product Collateral | ||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | ||||
| Increase Decrease In Operating Lease Liability | ||||
| Increase Decrease In Derivative Liabilities | ||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | ||||
| Increase Decrease In Accounts Receivable | ||||
| Increase Decrease In Accounts Payable | ||||
| Depreciation Depletion And Amortization |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Temporary Equity Shares Outstanding | 0.00 | 258.5M | 258.5M | 258.5M |
| Weighted Average Number Of Shares Outstanding Basic | 236.3M | 64.9M | 63.1M | |
| Weighted Average Number Of Diluted Shares Outstanding | 236.3M | 64.9M | 63.1M | |
| Earnings Per Share Diluted | $-4.27 | $-0.39 | $-3.22 | |
| Earnings Per Share Basic | $-4.27 | $-0.39 | $-3.22 | |
| Temporary Equity Shares Issued | 0.00 | 258.5M | ||
| Temporary Equity Shares Authorized | 0.00 | 258.6M | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | ||
| Preferred Stock Shares Authorized | 100.0M | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 258.5M | 258.5M | 258.5M | 258.5M |
| Weighted Average Number Of Shares Outstanding Basic | 371.8M | 126.6M | 65.1M | 64.7M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 371.8M | 126.6M | 65.1M | 64.7M | ||
| Earnings Per Share Diluted | $-0.15 | $-7.29 | $-0.34 | $0.00 | ||
| Earnings Per Share Basic | $-0.15 | $-7.29 | $-0.34 | $0.00 | ||
| Temporary Equity Shares Issued | 0.00 | 0.00 | ||||
| Temporary Equity Shares Authorized | 0.00 | 0.00 | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | ||||
| Preferred Stock Shares Authorized | 100.0M | 100.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $25.2M | $1.4M | $1.7M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.07B | $29.8M | $26.3M |
| Transaction And Risk Losses | $407.3M | $219.7M | $152.4M |
| Member Support And Operations | $458.0M | $286.9M | $272.8M |
| Stock Repurchased And Retired During Period Value | $77.5M | $853.0K | $55.0K |
| Provision For Transaction Dispute Losses | $63.6M | $50.6M | $67.4M |
| Provision For Doubtful Accounts | $77.7M | $33.5M | $0.00 |
| Noncash Contribution Expense | $11.2M | $0.00 | $0.00 |
| Interest Paid Net | $330.0K | $467.0K | $54.0K |
| Product Collateral Current | $251.2M | $181.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $9.8M | $410.0K | $717.0K | $307.0K | $392.0K | $208.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $85.5M | $910.3M | $8.7M | $10.1M | $6.4M | $5.2M |
| Transaction And Risk Losses | $97.1M | $98.2M | $55.2M | $35.0M | ||
| Member Support And Operations | $83.7M | $203.1M | $70.1M | $69.8M | ||
| Stock Repurchased And Retired During Period Value | $316.0K | $510.0K | $27.0K | |||
| Provision For Transaction Dispute Losses | ||||||
| Provision For Doubtful Accounts | ||||||
| Noncash Contribution Expense | ||||||
| Interest Paid Net | ||||||
| Product Collateral Current | $229.0M | $213.0M |
Most recent annual filing with the SEC: March 6, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.